Belite Bio Inc ADR (BLTE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -36,144 | -26,044 | N/A | N/A | -31,632 |
| Depreciation Amortization | 449 | 331 | N/A | N/A | 399 |
| Other Working Capital | 2,245 | -1,062 | N/A | N/A | -2,183 |
| Other Operating Activity | 4,216 | 2,142 | 0 | 0 | 3,579 |
| Operating Cash Flow | $-29,234 | $-24,633 | $N/A | $N/A | $-29,837 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -4,500 | -4,500 | N/A | N/A | N/A |
| PPE Investments | -116 | -116 | N/A | N/A | -63 |
| Purchase Of Investment | -183,765 | -120,813 | N/A | N/A | N/A |
| Sale Of Investment | 77,844 | 40,900 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -35 | -29 | N/A | N/A | N/A |
| Other Investing Activity | -35 | -29 | 0 | 0 | 0 |
| Investing Cash Flow | $-110,572 | $-84,558 | $N/A | $N/A | $-63 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 83,201 | 44,039 | N/A | N/A | 77,189 |
| Other Financing Activity | 394 | -219 | 0 | 0 | -1,230 |
| Financing Cash Flow | $83,595 | $43,820 | $N/A | $N/A | $75,959 |
| Exchange Rate Effect | -269 | 8 | N/A | N/A | 9 |
| Beginning Cash Position | 88,157 | 88,157 | N/A | N/A | 42,089 |
| End Cash Position | 31,677 | 22,794 | N/A | N/A | 88,157 |
| Net Cash Flow | $-56,480 | $-65,363 | $N/A | $N/A | $46,068 |
| Free Cash Flow | |||||
| Operating Cash Flow | -29,234 | -24,633 | N/A | N/A | -29,837 |
| Capital Expenditure | -116 | -116 | N/A | N/A | -63 |
| Free Cash Flow | -29,350 | -24,749 | 0 | 0 | -29,900 |